Education
About Us
Working with TipRanks
Follow Us
Cizzle Biotechnology Holdings PLC (GB:CIZ)
LSE:CIZ
CIZ Stock Chart & Stats
Day’s Range― - ―
52-Week Range1.30p - 2.69p
Previous CloseN/A
Volume291.66K
Average Volume (3M)543.32K
Market Cap
£7.33M
Enterprise ValueN/A
Total Cash (Recent Filing)£816.00K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.61
Next Earnings
Sep 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding396,391,780
10 Day Avg. Volume994,960
30 Day Avg. Volume543,315
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cizzle Biotechnology Holdings PLC News
PremiumCompany Announcements
Cizzle Biotechnology Holdings PLC Announces Change in Major Holdings
PremiumCompany Announcements
Cizzle Biotechnology Expands CIZ1B Biomarker Test to Caribbean
PremiumCompany Announcements
Cizzle Biotechnology Launches New Website to Support Growth Strategy
PremiumCompany Announcements
Cizzle Biotechnology to Launch CIZ1B Biomarker Test in the USA
PremiumCompany Announcements
Cizzle Biotechnology Appoints New CSO Amidst Lung Cancer Test AdvancementsCIZ FAQ
What was Cizzle Biotechnology Holdings PLC’s price range in the past 12 months?
Cizzle Biotechnology Holdings PLC lowest share price was 1.30p and its highest was 2.69p in the past 12 months.
What is Cizzle Biotechnology Holdings PLC’s market cap?
Cizzle Biotechnology Holdings PLC’s market cap is £7.33M.
When is Cizzle Biotechnology Holdings PLC’s upcoming earnings report date?
Cizzle Biotechnology Holdings PLC’s upcoming earnings report date is Sep 25, 2025 which is in 120 days.
How were Cizzle Biotechnology Holdings PLC’s earnings last quarter?
Cizzle Biotechnology Holdings PLC released its earnings results on Apr 30, 2025. The company reported -0.002p earnings per share for the quarter, missing the consensus estimate of N/A by -0.002p.
Is Cizzle Biotechnology Holdings PLC overvalued?
According to Wall Street analysts Cizzle Biotechnology Holdings PLC’s price is currently Overvalued.
Does Cizzle Biotechnology Holdings PLC pay dividends?
Cizzle Biotechnology Holdings PLC does not currently pay dividends.
What is Cizzle Biotechnology Holdings PLC’s EPS estimate?
Cizzle Biotechnology Holdings PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cizzle Biotechnology Holdings PLC have?
Cizzle Biotechnology Holdings PLC has 396,391,780 shares outstanding.
What happened to Cizzle Biotechnology Holdings PLC’s price movement after its last earnings report?
Cizzle Biotechnology Holdings PLC reported an EPS of -0.002p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.125%.
Which hedge fund is a major shareholder of Cizzle Biotechnology Holdings PLC?
Currently, no hedge funds are holding shares in GB:CIZ
Company Description
Cizzle Biotechnology Holdings PLC
Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Technical Analysis
Evgen Pharma
―
Oxford BioDynamics
―
HemoGenyx Pharmaceuticals Plc
―
Fusion Antibodies Plc
―
Aptamer Group Plc
―